EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Restoring colistin sensitivity in colistin-resistant Salmonella and Escherichia coli : combinatorial use of berberine and EDTA with colistin

Xiao-Die Cui, Xiao-Kang Liu, Xiao-Yuan Ma, Shuai-Hua Li, Jun-Kai Zhang, Rong-Jia Han, Kai-Fang Yi, Jian-Hua Liu, Yu-Shan Pan, Dan-Dan He, Gong-Zheng Hu iD, Ya-Jun Zhai iD

mSphere · 2024

DOI: 10.1128/msphere.00182-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2024. Verfasst von Xiao-Die Cui und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China. Hauptthemen laut MEDLINE: Colistin, Berberine, Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China, National Natural Science Foundation Youth Found.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The appearance and prevalence of multidrug-resistance (MDR) Gram-negative bacteria (GNB) have limited our antibiotic capacity to control bacterial infections. The clinical efficacy of colistin (COL), considered as the “last resort” for treating GNB infections, has been severely hindered by its increased use as well as the emergence and prevalence of mobile colistin resistance (MCR)-mediated acquired drug resistance. Identifying promising compounds to restore antibiotic activity is becoming an effective strategy to alleviate the crisis of increasing MDR. We first demonstrated that the combination of berberine (BBR) and EDTA substantially restored COL sensitivity against COL-resistant Salmonella and Escherichia coli . Molecular docking indicated that BBR can interact with MCR-1 and the efflux pump system AcrAB-TolC, and BBR combined with EDTA downregulated the expression level of mcr-1 and tolC . Mechanically, BBR combined with EDTA could increase bacterial membrane damage, inhibit the function of multidrug efflux pump, and promote oxidative damage, thereby boosting the action of COL. In addition, transcriptome analysis found that the combination of BBR and EDTA can accelerate the tricarboxylic acid cycle, inhibit cationic antimicrobial peptide (CAMP) resistance, and attenuate Salmonella virulence. Notably, the combination of BBR and EDTA with COL significantly reduced the bacterial load in the liver and spleen of a mice model infected with Salmonella . Our findings revealed that BBR and EDTA can be used as adjuvants collectively with COL to synergistically reverse the COL resistance of bacteria. IMPORTANCE Colistin is last-resort antibiotic used to treat serious clinical infections caused by MDR bacterial pathogens. The recent emergence of transferable plasmid-mediated COL resistance gene mcr-1 has raised the specter of a rapid worldwide spread of COL resistance. Coupled with the fact of barren antibiotic development pipeline nowadays, a critical approach is to revitalize existing antibiotics using antibiotic adjuvants. Our research showed that berberine combined with EDTA effectively reversed COL resistance both in vivo and in vitro through multiple modes of action. The discovery of berberine in combination with EDTA as a new and safe COL adjuvant provides a therapeutic regimen for combating Gram-negative bacteria infections. Our findings provide a potential therapeutic option using existing antibiotics in combination with antibiotic adjuvants and address the prevalent infections caused by MDR Gram-negative pathogens worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinBerberineEscherichia coliAnti-Bacterial AgentsEdetic AcidSalmonellaAnimalsMiceDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsEscherichia coli InfectionsFemaleEscherichia coli ProteinsMolecular Docking SimulationDrug Resistance, BacterialDrug Therapy, CombinationMice, Inbred BALB CDrug Synergism

Stichwörter der Autor:innen

BerberineColistinEDTAEscherichia coliSalmonella

Substanzen

ColistinBerberineAnti-Bacterial AgentsEdetic AcidEscherichia coli Proteins

Autor:innen und Institutionen

  • College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, China.

ORCID-Profile: Gong-Zheng Hu, Ya-Jun Zhai

Förderung

  • MOST | National Natural Science Foundation of China
  • National Natural Science Foundation Youth Found

Zitieren

APA

Cui, X., Liu, X., Ma, X., Li, S., Zhang, J., Han, R., Yi, K., Liu, J., Pan, Y., He, D., Hu, G., & Zhai, Y. (2024). Restoring colistin sensitivity in colistin-resistant Salmonella and Escherichia coli : combinatorial use of berberine and EDTA with colistin. mSphere. https://doi.org/10.1128/msphere.00182-24

Vancouver

Cui X, Liu X, Ma X, Li S, Zhang J, Han R, et al. Restoring colistin sensitivity in colistin-resistant Salmonella and Escherichia coli : combinatorial use of berberine and EDTA with colistin. mSphere. 2024. doi:10.1128/msphere.00182-24

BibTeX
@article{Cui2024,
  author = {Cui, Xiao-Die and Liu, Xiao-Kang and Ma, Xiao-Yuan and Li, Shuai-Hua and Zhang, Jun-Kai and Han, Rong-Jia and Yi, Kai-Fang and Liu, Jian-Hua and Pan, Yu-Shan and He, Dan-Dan and Hu, Gong-Zheng and Zhai, Ya-Jun},
  title = {Restoring colistin sensitivity in colistin-resistant Salmonella and Escherichia coli : combinatorial use of berberine and EDTA with colistin},
  journal = {mSphere},
  year = {2024},
  doi = {10.1128/msphere.00182-24}
}
Kostenlos starten →